Brain Tumor, Recurrent

Known as: Recurrent Brain Neoplasm, Recurrent Brain Tumors, brain tumors recurrent 
The reemergence of a brain neoplasm after a period of remission.
National Institutes of Health

Related topics

Related topics

8 relations
Benign neoplasm of brain, unspecifiedBrainCentral Nervous SystemNeoplastic Cell
(More)

Broader (1)

Brain Neoplasms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
UNLABELLED We evaluated the diagnostic accuracy of PET with l-methyl-(11)C-methionine ((11)C-MET) for the differentiation of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.
UNLABELLED alpha-Particle-emitting radionuclides, such as (211)At, with a 7.2-h half-life, may be optimally suited for the… (More)
Is this relevant?
Review
2005
Review
2005
PET imaging for differentiating recurrent brain tumor from radiation necrosis.
The exact incidence of true radiation necrosis is largely unknown. It is probably much less frequent than indicated by MR or CT… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
PURPOSE Methyl-[11C]L-methionine ([11C]MET) positron emission tomography (PET) in brain tumors reflects amino acid transport and… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
OBJECT Following stereotactic radiosurgery (SRS), we examined how to differentiate radiation necrosis from recurrent malignant… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2004
2004
Textiloma (gossypiboma) mimicking recurrent intracranial tumor.
CONTEXT Resorbable substances used to achieve hemostasis during neurosurgical procedures comprise 3 principal classes based on… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.
Current treatments for brain cancer have, for the most part, equivocal survival benefit. However, clinical trials of new… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Radiation necrosis and recurrent brain tumor have similar symptoms and are indistinguishable on both magnetic resonance imaging… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
We studied 15 patients clinically suspected to have recurrent brain tumor or radiation injury, using positron emission tomography… (More)
Is this relevant?